Jodie Pope Morrison

Insider Reports History

Location
C/O Tokai Pharmaceuticals, Inc., One Broadway, 14 Th Floor, Cambridge, MA
Signature
/s/ Eric Bell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jodie Pope Morrison:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Q32 Bio Inc. CEO, Director Stock Option (Right to Buy) 394K $5.29M $13.42 Feb 24, 2025 Direct
Q32 Bio Inc. CEO, Director Common Stock 122K $219K $1.80 Aug 26, 2025 Direct
AILERON THERAPEUTICS INC Director Stock Option (right to buy) 54.5K Jun 15, 2022 Direct
Verve Therapeutics, Inc. Director Stock Option (right to buy) 0 Jul 25, 2025 Direct

Insider Reports Filed by Jodie Pope Morrison

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QTTB Q32 Bio Inc. Aug 26, 2025 1 -$18.9K 4 Aug 28, 2025 CEO, Director
VERV Verve Therapeutics, Inc. Jul 25, 2025 2 $0 4 Jul 28, 2025 Director
VERV Verve Therapeutics, Inc. Jun 5, 2025 1 $0 4 Jun 6, 2025 Director
QTTB Q32 Bio Inc. Feb 24, 2025 9 $0 4 Feb 26, 2025 CEO, Director
VERV Verve Therapeutics, Inc. Jun 26, 2024 1 $0 4 Jun 28, 2024 Director
VERV Verve Therapeutics, Inc. Jun 26, 2024 0 $0 3 Jun 28, 2024 Director
QTTB Homology Medicines, Inc. Mar 25, 2024 1 $0 4 Mar 27, 2024 CEO, Director
QTTB Homology Medicines, Inc. Mar 25, 2024 0 $0 3 Mar 27, 2024 CEO, Director
ALRN AILERON THERAPEUTICS INC Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
ALRN AILERON THERAPEUTICS INC Jun 15, 2021 1 $0 4 Jun 17, 2021 Director